The Norepinephrine Transporter: A Novel Target for Imaging Brown Adipose Tissue
Information source: Yale University
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Brown Adipose Tissue
Intervention: PET imaging (Radiation)
Phase: Phase 0
Status: Completed
Sponsored by: Yale University Official(s) and/or principal investigator(s): Robert Sherwin, MD, Principal Investigator, Affiliation: Yale University
Summary
This study seeks to assess a novel imaging technique to image brown adipose tissue utilizing
the norepinephrine transporter.
Clinical Details
Official title: The Norepinephrine Transporter: A Novel Target for Imaging Brown Adipose Tissue
Study design: Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Primary outcome: detection of brown adipose tissue based on PET imaging
Eligibility
Minimum age: 18 Years.
Maximum age: 30 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- age 18-30 yrs
- BMI < 24 kg/m2
- Caucasian
Exclusion Criteria:
- Current neuro-psychiatric illness
- substance abuse
- medical or neurological illnesses likely to affect physiology or anatomy, i. e.,
uncontrolled hypertension, cardiovascular disorders
- current pregnancy
- current breast feeding
- suicidal ideation or behavior
- use of medications which potentially affect NET binding within 2 weeks of the PET
scans.
Locations and Contacts
Yale University, New haven, Connecticut 06510, United States
Additional Information
Starting date: September 2012
Last updated: July 16, 2015
|